Cellebrite Di (CLBT): Officer sold ~$106K
Marcus Jewell, Officer at Cellebrite Di, sold ~$106K of Cellebrite Di shares.
- ~$106K
- Approx. value · 9,928 sh @ $10.66
- 404K
- Holds after · shares reported
- Traded
- Nov 17, 2026
- Filed
- Nov 18, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 9, 20265% stakePertento Partners LLP reported a passive stake (13G) of 5.2%
- Oct 16, 2026InsiderCFO sold ~$136K of CLBT shares in the open market
- Nov 12, 2026Insider · 2 peopleInsiders: 2 sales (~$8K)
- Nov 16, 2026InsiderOfficer sold ~$144K of CLBT shares in the open market
- Nov 17, 2026 · this disclosureInsiderOfficer sold ~$106K of CLBT shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Cellebrite Di
For Cellebrite Di, OQRO holds 12 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CLBT page.
Other recent filings by Marcus Jewell, Global Chief Revenue Officer
- SEC Form 4 at Cellebrite Di (CLBT)Nov 18, 2026
- SEC Form 4 at Cellebrite Di (CLBT)Nov 12, 2026
- SEC Form 4 at Cellebrite Di (CLBT)Aug 25, 2026
- SEC Form 4 at Cellebrite Di (CLBT)Aug 13, 2026
- SEC Form 4 at Cellebrite Di (CLBT)May 19, 2026
The full history of Marcus Jewell, Global Chief Revenue Officer is on the profile page.
How this filing works
Explore the data
Common questions
Which Cellebrite Di (CLBT) insider traded, and how much?
Marcus Jewell, Officer at Cellebrite Di, sold ~$106K of Cellebrite Di shares. 9,928 shares at $10.66.
When did it happen, and when was it made public?
Traded: Nov 17, 2026. Filed: Nov 18, 2026. That is 1 day between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Cellebrite Di recently?
For Cellebrite Di, OQRO holds 12 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the CLBT page.
Does this mean CLBT stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Cellebrite Di
- SEC Form 4Nov 18, 2026
- SEC Form 144Nov 17, 2026
- SEC Form 4Nov 13, 2026
- SEC Form 4Nov 12, 2026
- SEC Form 144Nov 10, 2026
- SEC Form 144Nov 10, 2026
Everything OQRO holds on this company is on its CLBT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
